MedPath

Effect of Nettle in treatment of menopausal hot flash

Phase 3
Conditions
Menopause.
Menopausal and female climacteric states
Registration Number
IRCT20110809007265N11
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
42
Inclusion Criteria

Post-menopausal women (defined as: amenorrhea for 12 months or more) who suffer from hot flashes.
Age 45-60 years old
Approval for treatment of hot flashes and consent to participate in the plan.

Exclusion Criteria

History of hysterectomy or oophorectomy
Anticancer therapies due to malignancy
History of estrogen-dependent cancers over the past five years
History of allergy to urticaria
History of known psychiatric disorders
Hyperthyroidism or hypothyroidism
Conditions and physical illnesses that are not suitable for this study: Cardiovascular disease (coronary artery disease, cerebrovascular disease and thromboembolic disorders) uncontrolled Hypertension or diabetes, kidney or liver failure
use of anticoagulants
Taking any medication for hot flashes such as HRT and SSRI in the past eight weeks
Endometrial thickness over 12 mm in uterine ultrasonography
Vaginal bleeding with unknown origin in the past 6 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evel of FSH, estradiol, LH. Timepoint: Before the study and at week 8. Method of measurement: blood test.;Severity of menopausal symptoms. Timepoint: Before the intervention, week 4 and 7. Method of measurement: Menopausal Rating Scale questionnaire.;Number and severity of hot flashes per day. Timepoint: One week before the study and at weeks 5 and 8. Method of measurement: Patient Daily Report.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath